CDKN2A and breast cancer: When cultured in vitro, these vHMECs went on to acquire chromosomal abnormalities seen in premalignant lesions of breast cancer and further progressed to display invasive behaviour, suggesting that p16 inactivation identifies a sub-population of mammary epithelial cells, which possess the potential to develop into malignant lesions (Crawford et al, 2004).